Our results showed that FTD-iAs have similar expression levels of both GLT1 and GLAST compared to Control-iAs, suggesting that differences in glutamate uptake were not due to an increased expression levels of glutamate transporter mRNA in FTD-iAs (Supplementary Fig. 6E). The gene discussed is SLC1A2; the disease is frontotemporal dementia.